Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal proliferation of cytotoxic lymphocytes. Among them, ...

Emily Taylor said her 7-year-old son Jerett, who goes by Rett, was first diagnosed with T-cell acute lymphoblastic leukemia ...

A KAIST research team has identified the real reason why anticancer drugs kill cancer cells—targeted anticancer therapies do ...

Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer ...

Has come back (relapsed) within a year of treatment or does not go away (refractory) after your first treatment Has relapsed or is refractory and you cannot receive a hematopoietic stem cell ...

It may be possible to identify which pre-cancerous cells will develop into a rare type of blood cancer, due to new research ...

Despite major advances in immunotherapy—including the 2025 Nobel Prize in Physiology or Medicine recognizing advances in peripheral immune tolerance—progress against leukemia has remained limited.